BCL2 and non-Hodgkin lymphoma: Depending on the subtype of NHL, Brentuximab–Vedotin, tyrosine kinase or BCL-2 inhibitors, immunotherapy, radiotherapy, or hematopoietic stem cell autotransplantation (refractory or relapsed NHL) may be used [93,96].